SCHEMBL925959

SCHEMBL925959

CC(C)OC=Cc1ccc(C=CC(=O)O)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.61
MAPK1 P28482 3/20 0.61
THRB P10828 2/20 0.56
ATM Q13315 1/20 0.56
CA12 O43570 4/20 0.53
CA1 P00915 4/20 0.53
CA2 P00918 4/20 0.53
CA7 P43166 4/20 0.53
CA9 Q16790 4/20 0.53
CA14 Q9ULX7 4/20 0.53
AKR1B10 O60218 3/20 0.53
AKR1B1 P15121 3/20 0.53
CA3 P07451 3/20 0.53
CA4 P22748 3/20 0.53
CA6 P23280 3/20 0.53
CA5A P35218 3/20 0.53
CA5B Q9Y2D0 3/20 0.53
PKM P14618 3/20 0.53
HCAR2 Q8TDS4 2/20 0.53
DPP4 P27487 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1207346 0.79 THRB (0.66) KDM4EMAPK1THRBATMCA12
SCHEMBL1207345 0.79 THRB (0.66) KDM4EMAPK1THRBATMCA12
SCHEMBL14081549 0.78 HCAR2 (0.81) KDM4EMAPK1THRBATMCA12
SCHEMBL713717 0.78 HCAR2 (0.81) KDM4EMAPK1THRBATMCA12
SCHEMBL68395 0.78 HCAR2 (0.81) KDM4EMAPK1THRBATMCA12
SCHEMBL23134220 0.77 MAOB (0.44) KDM4EMAPK1HSD17B10HPGDSMN1; SMN2
SCHEMBL419698 0.77 MAOB (0.44) KDM4EMAPK1HSD17B10HPGDSMN1; SMN2
SCHEMBL18662489 0.76 HCAR2 (0.77) KDM4EMAPK1THRBATMCA12
Hydrochloric Acid SCHEMBL8378608 0.76 HCAR2 (0.77) KDM4EMAPK1THRBATMCA12
Hydrochloric Acid SCHEMBL11835203 0.76 HCAR2 (0.77) KDM4EMAPK1THRBATMCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009621-A1 SUPPORTED TRANSITION METAL COMPLEX AND USE THEREOF IN CATALYSIS Raap Polymere GmbH (DE) 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009621-A1 SUPPORTED TRANSITION METAL COMPLEX AND USE THEREOF IN CATALYSIS SCO2, SOD1, PPIF KDM4E 4042/4885MAPK1 3084/4885THRB 4742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.